NEW YORK ( TheStreet) -- Ligand Pharmaceuticals (Nasdaq: LGND) hit a new 52-week high Tuesday as it is currently trading at $16.27, above its previous 52-week high of $16.24 with 67,799 shares traded as of 1:59 p.m. ET. Average volume has been 145,900 shares over the past 30 days. Ligand has a market cap of $248.1 million and is part of the health care sector and drugs industry. Shares are up 34.5% year to date as of the close of trading on Monday. Ligand Pharmaceuticals Incorporated operates as a biotechnology company. It principally engages in the development and acquisition of royalty revenue generating assets. The company has a P/E ratio of 30.4, above the average drugs industry P/E ratio of 27.4 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter